Habit dominates USA TODAY 10Best and makes sure the competition sees it IRVINE, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — The grills at Habit Burger & Grill aren't the only things heating up this summer. After its Double Char was voted #1 in its nominated category1, its Tempura Green Beans also ranked #12, and the […]
(TASE:BWAY.TA),(NasdaqGM:BWAY), Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.5 million, Raised full-year 2025 Revenue and EBITDA guidance Remaining performance obligations increased by 25% YOY to $62 million Conference call to be held today at
(NASDAQ:PYPD), Positive Phase 3 SHIELD II Trial Results – D-PLEXâ‚₀₀ successfully met its primary efficacy endpoint and demonstrated 58% reduction in SSI NDA submission expected in Q1 2026 Unveiled a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Obesity and Diabetes Market Successful Warrant Exercise Significantly Strengthened Balance Sheet with Cash Runway into 2026 Conference
Creative Realities Reports Fiscal 2025 Second Quarter Results Revenue Growth Picks Up as Year Progresses; Company on Track for Record 2025 GlobeNewswire August 13, 2025 LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today
Humanoid Global Announces Uplisting to the OTCQB Market – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – GlobeNewswire August 13, 2025 Vancouver, BC, Aug. 13, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company“) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements GlobeNewswire August 13, 2025 Business development: Purchased mezagitamab royalty and milestone rights held by BioInvent International and will secure royalty economic interests in two early-stage partnered assets through XOMA Royalty's recently announced acquisition of LAVA Therapeutics. Company acquisitions:
Digi Power X to Announce 2025 Q2 Financial Results on August 14th GlobeNewswire August 13, 2025 This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Aug. 13, 2025 (GLOBE NEWSWIRE) — Digi
Amerigo's MVC Resumes Fresh Tailings Processing GlobeNewswire August 13, 2025 El Teniente restarts operations and is sending fresh tailings to MVC Historic tailings processing remains ongoing Timing of normalized operations at El Teniente to determine impact on MVC guidance VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF)
Sagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates GlobeNewswire August 13, 2025 Denifanstat met all primary and secondary endpoints in Phase 3 clinical trial in moderate to severe acne conducted by license partner Ascletis in China Initiated first-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 being developed for acne in
MasterCraft Boat Holdings, Inc. to Webcast Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call Wednesday, August 27, 2025 Live webcast at 8:30 a.m. EDT GlobeNewswire August 13, 2025 VONORE, Tenn., Aug. 13, 2025 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) will host a live webcast of its fiscal fourth